David M. Goldenberg – författare

How old is prejudice against black people? Were the racist attitudes that fueled the Atlantic slave trade firmly in place 700 years before the European discovery of sub-Saharan Africa? In this groundbreaking book, David Goldenberg seeks to discover how dark-skinned peoples, especially black Africans, were portrayed in the Bible and by those who interpreted the Bible--Jews, Christians, and Muslims. Unprecedented in rigor and breadth, his investigation covers a 1,500-year period, from ancient Israel (around 800 B.C.E.) to the eighth century C.E., after the birth of Islam. By tracing the development of anti-Black sentiment during this time, Goldenberg uncovers views about race, color, and slavery that took shape over the centuries--most centrally, the belief that the biblical Ham and his descendants, the black Africans, had been cursed by God with eternal slavery. Goldenberg begins by examining a host of references to black Africans in biblical and postbiblical Jewish literature. From there he moves the inquiry from Black as an ethnic group to black as color, and early Jewish attitudes toward dark skin color.He goes on to ask when the black African first became identified as slave in the Near East, and, in a powerful culmination, discusses the resounding influence of this identification on Jewish, Christian, and Islamic thinking, noting each tradition's exegetical treatment of pertinent biblical passages. Authoritative, fluidly written, and situated at a richly illuminating nexus of images, attitudes, and history, The Curse of Ham is sure to have a profound and lasting impact on the perennial debate over the roots of racism and slavery, and on the study of early Judaism, Christianity, and Islam.

Where do you begin to look for a recent, authoritative article on the diagnosis or management of a particular malignancy? The few general oncology text­ books are generally out of date. Single papers in specialized journals are informative but seldom comprehensive; these are more often preliminary reports on a very limited number of patients. Certain general journals frequently publish good in-depth reviews of cancer topics, and published symposium lectures are often the best overviews available. Unfortunately, these reviews and supplements appear sporadically, and the reader can never be sure when a topic of special interest will be covered. Cancer Treatment and Research is a series of authoritative volumes that aim to meet this need. It is an attempt to establish a critical mass of oncology literature covering virtually all oncology topics, revised frequently to keep the coverage up to date, and easily available on a single library shelf or by a single personal subscription. We have approached the problem in the following fashion: first, by dividing the oncology literature into specific subdivisions such as lung cancer, genitourinary cancer, pediatric oncology, etc.; and second, by asking eminent authorities in each of these areas to edit a volume on the specific topic on an annual or biannual basis. Each topic and tumor type is covered in a volume appearing frequently and predictably, discussing current diagnosis, staging, markers, all forms of treatment modalities, basic biology, and more.

Cancer Therapy with Radiolabeled Antibodies explores the most current experimental and clinical advances in the newly emerging field of cancer radioimmunotherapy (RAIT). Providing a multidisciplinary and international context, some of the world's leading experts examine the problems and prospects of RAIT from radiation, immunological, chemical, physical, physiological, and clinical perspectives with both overviews and original research.Discussions cover the up-to-date clinical results in the RAIT of ovarian, breast, colorectal, and brain cancers, as well as the current status of RAIT in the management of B cell lymphomas. Radiobiology, dosimetry, radiochemistry, targeting biology in experimental models, clinical experiences in hematopoietic and solid tumors, and new approaches to improve cancer radioimmunotherapy are also discussed. In addition, new dosimetry concepts, new labeling methods, new concepts of antibody pharmacokinetics, and new methods to enhance selective cancer radioimmunotherapy are included.

Where do you begin to look for a recent, authoritative article on the diagnosis or management of a particular malignancy? The few general oncology text­ books are generally out of date. Single papers in specialized journals are informative but seldom comprehensive; these are more often preliminary reports on a very limited number of patients. Certain general journals frequently publish good in-depth reviews of cancer topics, and published symposium lectures are often the best overviews available. Unfortunately, these reviews and supplements appear sporadically, and the reader can never be sure when a topic of special interest will be covered. Cancer Treatment and Research is a series of authoritative volumes that aim to meet this need. It is an attempt to establish a critical mass of oncology literature covering virtually all oncology topics, revised frequently to keep the coverage up to date, and easily available on a single library shelf or by a single personal subscription. We have approached the problem in the following fashion: first, by dividing the oncology literature into specific subdivisions such as lung cancer, genitourinary cancer, pediatric oncology, etc.; and second, by asking eminent authorities in each of these areas to edit a volume on the specific topic on an annual or biannual basis. Each topic and tumor type is covered in a volume appearing frequently and predictably, discussing current diagnosis, staging, markers, all forms of treatment modalities, basic biology, and more.